| Product NDC: | 0006-3918 |
| Proprietary Name: | SINEMET |
| Non Proprietary Name: | carbidopa and levodopa |
| Active Ingredient(s): | 25; 100 mg/1; mg/1 & nbsp; carbidopa and levodopa |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0006-3918 |
| Labeler Name: | Merck Sharp & Dohme Corp. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA019856 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19910530 |
| Package NDC: | 0006-3918-68 |
| Package Description: | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0006-3918-68) |
| NDC Code | 0006-3918-68 |
| Proprietary Name | SINEMET |
| Package Description | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0006-3918-68) |
| Product NDC | 0006-3918 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | carbidopa and levodopa |
| Dosage Form Name | TABLET, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 19910530 |
| Marketing Category Name | NDA |
| Labeler Name | Merck Sharp & Dohme Corp. |
| Substance Name | CARBIDOPA; LEVODOPA |
| Strength Number | 25; 100 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes | Aromatic Amino Acid Decarboxylation Inhibitor [EPC],DOPA Decarboxylase Inhibitors [MoA],Aromatic Amino Acid Decarboxylation Inhibitor [EPC],DOPA Decarboxylase Inhibitors [MoA] |